Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Sektor | Analystenrating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND CO | 632,57 B CHF | 651,959 CHF | +0,06% | 73 | 3,09 | 84,16 | 7,75 CHF | +56,19% | 0,67% | Gesundheitstechnologie | Kauf |
LLYLILLY ELI | 632,57 B CHF | 665 CHF | −3,62% | 20 | 1,35 | 85,84 | 7,75 CHF | +56,19% | 0,67% | Gesundheitstechnologie | Kauf |
NOVNOVO NORDISK A/S | 409,12 B CHF | 90,237 CHF | −2,15% | 191 | 0,46 | 33,66 | 2,68 CHF | +23,88% | 1,34% | Gesundheitstechnologie | Kauf |
JNJJOHNSON & JOHNSON | 326,03 B CHF | 135,090 CHF | +0,14% | 1 | 0,03 | 26,35 | 5,13 CHF | +6,88% | 3,17% | Gesundheitstechnologie | Kauf |
4ABABBVIE INC | 262,19 B CHF | 146,748 CHF | −3,28% | 10 | 0,15 | 60,39 | 2,43 CHF | −27,36% | 3,70% | Gesundheitstechnologie | Kauf |
6MKMERCK & CO INC | 218 B CHF | 84,372 CHF | −3,52% | 7 | 0,55 | 20,85 | 4,05 CHF | +145,49% | 3,16% | Gesundheitstechnologie | Kauf |
ROGROCHE GS | 201,08 B CHF | 250,7 CHF | +0,60% | 563,79 K | 0,45 | 18,95 | 13,23 CHF | — | 3,85% | Gesundheitstechnologie | Neutral |
RHO5ROCHE HLDGS AG | 201,08 B CHF | 250,390 CHF | +0,44% | 99 | 0,07 | 18,93 | 13,23 CHF | — | 3,85% | Gesundheitstechnologie | Neutral |
RHOROCHE HLDGS AG | 201,08 B CHF | 267,912 CHF | +0,67% | 3 | 0,05 | 20,25 | 13,23 CHF | — | 3,63% | Gesundheitstechnologie | Neutral |
ROROCHE I | 201,08 B CHF | 265,4 CHF | +0,38% | 17,15 K | 0,61 | 20,06 | 13,23 CHF | — | 3,63% | Gesundheitstechnologie | Neutral |
NOTNOVARTIS AG | 180,23 B CHF | 91,462 CHF | +0,74% | 3,05 K | 1,12 | 12,06 | 7,58 CHF | +122,97% | 3,63% | Gesundheitstechnologie | Neutral |
NOVNEENOVARTIS N 2. LINIE | 180,23 B CHF | 91,48 CHF | +0,69% | 400 K | 1,00 | 12,06 | 7,58 CHF | +122,97% | 3,63% | Gesundheitstechnologie | — |
NOVNNOVARTIS N | 180,23 B CHF | 91,49 CHF | +0,55% | 1,64 M | 0,48 | 12,06 | 7,58 CHF | +122,97% | 3,63% | Gesundheitstechnologie | Neutral |
ZEGASTRAZENECA PLC | 172,92 B CHF | 112,650 CHF | +1,83% | 1 | 0,01 | 30,31 | 3,72 CHF | +8,34% | 2,34% | Gesundheitstechnologie | Kauf |
PFEPFIZER INC | 125 B CHF | 21,990 CHF | −1,29% | 7 | 0,03 | 34,88 | 0,63 CHF | −62,18% | 6,70% | Gesundheitstechnologie | Kauf |
VX1VERTEX PHARMACEUTICALS INC | 102,78 B CHF | 411,017 CHF | −4,72% | 20 | 0,94 | — | −1,69 CHF | −113,85% | 0,00% | Gesundheitstechnologie | Kauf |
RGOREGENERON PHARMACEUTICALS INC | 72,25 B CHF | 721,184 CHF | −24,11% | 60 | 5,94 | 21,06 | 34,25 CHF | +6,68% | 0,00% | Gesundheitstechnologie | Kauf |
ZOEZOETIS INC | 70,1 B CHF | 154,985 CHF | −5,12% | 25 | 1,19 | 34,38 | 4,51 CHF | +0,13% | 0,98% | Gesundheitstechnologie | Starker Kauf |
GS71GSK PLC | 59,33 B CHF | 14,726 CHF | −0,37% | 10 | 0,03 | 21,31 | 0,69 CHF | −58,28% | 4,62% | Gesundheitstechnologie | Neutral |
DULALNYLAM PHARMACEUT | 28,38 B CHF | 219,993 CHF | −6,71% | 36 | 0,44 | — | −2,22 CHF | +41,51% | 0,00% | Gesundheitstechnologie | Kauf |
GALDGALDERMA GROUP N | 20,42 B CHF | 85,37 CHF | −0,67% | 17,15 M | 88,20 | — | −0,05 CHF | — | 0,00% | Gesundheitstechnologie | Starker Kauf |
GALDGALDERMA GROUP AG | 20,42 B CHF | 86,835 CHF | +1,44% | 800 | 2,14 | — | −0,05 CHF | — | 0,00% | Gesundheitstechnologie | Starker Kauf |
IDPBIOGEN INC | 20,11 B CHF | 149,136 CHF | −14,64% | 50 | 3,01 | 15,90 | 9,38 CHF | +1,87% | 0,00% | Gesundheitstechnologie | Kauf |
BAYNBAYER AG | 17,9 B CHF | 18,008 CHF | −2,17% | 630 | 0,27 | — | −0,85 CHF | +76,60% | 0,56% | Gesundheitstechnologie | Neutral |
SDZSANDOZ GROUP N | 17,54 B CHF | 39,60 CHF | −0,68% | 383,69 K | 0,39 | — | — | — | 1,13% | Gesundheitstechnologie | Kauf |
D8YSANDOZ GROUP AG | 17,54 B CHF | 39,623 CHF | −1,24% | 1,08 K | 0,70 | — | — | — | 1,13% | Gesundheitstechnologie | Kauf |
ICYINCYTE CORPORATION | 12,11 B CHF | 62,149 CHF | −12,33% | 9 | — | 519,39 | 0,12 CHF | −93,06% | 0,00% | Gesundheitstechnologie | Kauf |
SRTSARTORIUS AG | 12,1 B CHF | 171,612 CHF | −1,64% | 3 | 0,21 | 150,18 | 1,14 CHF | −76,86% | 0,43% | Gesundheitstechnologie | Kauf |
HTDCORCEPT THERAPEUTI | 5,2 B CHF | 46,754 CHF | +112,01% | 430 | — | 43,88 | 1,07 CHF | +43,80% | 0,00% | Gesundheitstechnologie | Starker Kauf |
BANBBACHEM HOLDING AG | 5,08 B CHF | 72,578 CHF | −3,52% | 136 | 1,72 | 47,91 | 1,51 CHF | +11,74% | 1,18% | Gesundheitstechnologie | Neutral |
BANBBACHEM N | 5,08 B CHF | 69,70 CHF | +2,80% | 42,24 K | 0,60 | 46,01 | 1,51 CHF | +11,74% | 1,18% | Gesundheitstechnologie | Neutral |
SFZNSIEGFRIED N | 4,72 B CHF | 1.100 CHF | 0,00% | 3,19 K | 0,50 | 36,89 | 29,81 CHF | +0,16% | 0,33% | Gesundheitstechnologie | Kauf |
SQGSIEGFRIED HLDG AG | 4,72 B CHF | 1.099,724 CHF | −0,91% | 2 | 0,21 | 36,89 | 29,81 CHF | +0,16% | 0,33% | Gesundheitstechnologie | Kauf |
CN2CATALYST PHARMACEU | 2,23 B CHF | 20,217 CHF | +35,37% | 40 | — | 20,35 | 0,99 CHF | +105,76% | 0,00% | Gesundheitstechnologie | Starker Kauf |
EVTEVOTEC SE | 1,64 B CHF | 8,936 CHF | +11,76% | 3 K | 1,43 | — | −0,91 CHF | +7,49% | 0,00% | Gesundheitstechnologie | Kauf |
COPNCOSMO PHARM N | 1,05 B CHF | 61,8 CHF | −0,96% | 5,67 K | 0,39 | 14,92 | 4,14 CHF | +81,17% | 3,12% | Gesundheitstechnologie | Starker Kauf |
41XARDELYX INC | 1,03 B CHF | 4,351 CHF | −12,01% | 322 | 0,22 | — | −0,26 CHF | −131,15% | 0,00% | Gesundheitstechnologie | Starker Kauf |
5CVCUREVAC NV | 493,97 M CHF | 2,204 CHF | −0,32% | 20 | 0,06 | 4,79 | 0,46 CHF | — | 0,00% | Gesundheitstechnologie | Kauf |
PK5BASILEA PHARMACEU | 485,48 M CHF | 40,268 CHF | +1,48% | 200 | 0,93 | — | −0,28 CHF | −493,58% | 0,00% | Gesundheitstechnologie | Starker Kauf |
BSLNBASILEA N | 485,48 M CHF | 40,40 CHF | +0,12% | 15,67 K | 0,52 | — | −0,28 CHF | −493,58% | 0,00% | Gesundheitstechnologie | Starker Kauf |
0ETESPERION THERAPEUT | 419,98 M CHF | 2,110 CHF | +14,55% | 200 | — | — | −0,56 CHF | +74,24% | 0,00% | Gesundheitstechnologie | Kauf |
NWRNNEWRON PHARMA N | 136,21 M CHF | 7,32 CHF | +4,57% | 52,75 K | 0,84 | — | −0,99 CHF | −16,98% | 0,00% | Gesundheitstechnologie | Starker Kauf |
19TIDORSIA LTD | 130,25 M CHF | 0,752 CHF | −1,57% | 2,33 K | 0,58 | — | −1,59 CHF | +32,06% | 0,00% | Gesundheitstechnologie | Verkaufen |
IDIAIDORSIA N | 130,25 M CHF | 0,7500 CHF | +3,81% | 474,78 K | 0,38 | — | −1,59 CHF | +32,06% | 0,00% | Gesundheitstechnologie | Verkaufen |
SANNSANTHERA N | 76,32 M CHF | 8,22 CHF | −1,20% | 3,13 K | 0,20 | 1,43 | 5,76 CHF | — | 0,00% | Gesundheitstechnologie | Starker Kauf |
S3F0SANTHERA PHARMA | 76,32 M CHF | 8,377 CHF | −1,59% | 400 | 0,67 | 1,45 | 5,76 CHF | — | 0,00% | Gesundheitstechnologie | Starker Kauf |
CURNCURATIS N | 72,16 M CHF | 12,80 CHF | −14,67% | 14,98 K | 1,60 | — | −163,77 CHF | −896,07% | 0,00% | Gesundheitstechnologie | — |
RLFRELIEF THERAPEUTIC | 66,97 M CHF | 6,480 CHF | −1,29% | 5,76 K | — | — | −3,69 CHF | +20,81% | 0,00% | Gesundheitstechnologie | — |
RLFRELIEF THERAPEUTICS N | 66,97 M CHF | 5,22 CHF | −2,25% | 116,64 K | 0,61 | — | −3,69 CHF | +20,81% | 0,00% | Gesundheitstechnologie | — |
APEADDEX THERAPEUTICS | 11,02 M CHF | 0,081 CHF | −6,90% | 33 K | 2,47 | — | −0,02 CHF | +91,54% | 0,00% | Gesundheitstechnologie | Neutral |
ADXNADDEX N | 11,02 M CHF | 0,0564 CHF | −5,69% | 405,71 K | 0,43 | — | −0,02 CHF | +91,54% | 0,00% | Gesundheitstechnologie | Neutral |